AT
IBB icon

Avalon Trust’s iShares Biotechnology ETF IBB Stock Holding History

Avalon Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Sell
14,805
-220
-1% -$37.8K 0.17% 55
2026
Q1 		$2.54M Sell
15,025
-1,200
-7% -$205K 0.17% 53
2025
Q4 		$2.74M Sell
16,225
-103,022
-86% -$16.7M 0.18% 50
2025
Q3 		$17.2M Sell
119,247
-2,768
-2% -$378K 1.12% 23
2025
Q2 		$15.4M Sell
122,015
-5,030
-4% -$617K 1.13% 22
2025
Q1 		$16.2M Sell
127,045
-848
-0.7% -$115K 1.29% 23
2024
Q4 		$16.9M Buy
127,893
+935
+0.7% +$131K 1.2% 27
2024
Q3 		$18.5M Sell
126,958
-1,245
-1% -$180K 1.37% 26
2024
Q2 		$17.6M Buy
128,203
+3,155
+3% +$421K 1.39% 24
2024
Q1 		$17.2M Sell
125,048
-60
-0% -$8.19K 1.41% 27
2023
Q4 		$17M Sell
125,108
-478
-0.4% -$58.3K 1.55% 23
2023
Q3 		$15.4M Sell
125,586
-137
-0.1% -$17.4K 1.52% 27
2023
Q2 		$16M Sell
125,723
-882
-0.7% -$115K 1.44% 26
2023
Q1 		$16.4M Buy
+126,605
New +$16.6M 1.62% 26

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Avalon Trust's IBB Position: Q2 2026 in Review

Avalon Trust reduced its iShares Biotechnology ETF (IBB) stake by 1.5% in Q2 2026, selling an estimated $37.8K and leaving 14,805 shares worth $2.82M. The position accounts for 0.17% of the portfolio, ranked #55.

Avalon Trust first reported a position in IBB in Q1 2023 and has held it in 14 quarters since. The position peaked at $18.5M in Q3 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Avalon Trust held 14,805 shares of iShares Biotechnology ETF worth $2.82M as of Q2 2026.
  • Avalon Trust sold 220 iShares Biotechnology ETF shares in Q2 2026, an estimated $37.8K.
  • iShares Biotechnology ETF made up 0.17% of Avalon Trust's portfolio in Q2 2026, its #55 holding.
  • Avalon Trust first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 14 quarters since.
  • Avalon Trust's iShares Biotechnology ETF position peaked at $18.5M in Q3 2024.
  • 954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.